This is what trends in drug research look like
(SPENCER PHILLIPS HEY)
That’s a visual representation of what the world’s biggest drug makers have been up to in cardiology for the past 20 years. Each blob represents a clinical trial, and its size and shape signify how many patients it enrolled and whether it’s still running.
It’s pretty, and it’s also instructive, explains Spencer Phillips Hey, a professor at the Harvard Center for Bioethics who went to the trouble of downloading more than 13,000 trials' worth of data to create a sprawling, interactive portrait of pharmaceutical R&D, from which the above is clipped.
“Part of what is powerful about this bird’s-eye perspective is that after seeing and interacting with the data on this scale, questions about the stories, patterns, and outcomes that characterize the research enterprise as a whole become more concrete and accessible,” Phillips Hey writes.
Read more.
It’s pretty, and it’s also instructive, explains Spencer Phillips Hey, a professor at the Harvard Center for Bioethics who went to the trouble of downloading more than 13,000 trials' worth of data to create a sprawling, interactive portrait of pharmaceutical R&D, from which the above is clipped.
“Part of what is powerful about this bird’s-eye perspective is that after seeing and interacting with the data on this scale, questions about the stories, patterns, and outcomes that characterize the research enterprise as a whole become more concrete and accessible,” Phillips Hey writes.
Read more.
No hay comentarios:
Publicar un comentario